Rise in the prevalence of lifestyle-related diseases such as diabetes among people across the globe is driving the sales growth for the diabetic shoes market. Running shoes, dress shoes, ambulatory shoes, and strolling shoes are some of the products available in the market for diabetic shoes.
The global diabetic shoes market is projected to be valued at more than US$ 18.99 Bn by 2031, according to a study by Transparency Market Research (TMR). Moreover, the TMR assessment highlights that the market for diabetic shoes is prognosticated to register growth at a CAGR of 8.6% during the forecast period, 2021-2031.
To understand how our report can bring difference to your business strategy, Ask for a brochure
The diabetic shoes survey by TMR provides in-depth analysis of major factors impacting the growth curve of the global diabetic shoes market. Hence, this study covers thorough assessment on growth drivers, growth restraints, R&Ds, historical and present trends, regional analysis, and competition landscape of the market for diabetic shoes. Moreover, the study enlightens readers on emerging trends in the diabetic shoes market.
Due to increased adoption of unhealthy eating habits and wrong lifestyles, there has been a surge in the prevalence of lifestyle-associated diseases such as diabetes among people from across the globe. This factor is resulting into revenue-generation opportunities in the global diabetic shoes market.
Increase in Older Population Fuels Sales Growth in Diabetic Shoes Market
Generally, older population is found to be more prone to different health conditions such as diabetes owing to their compromised immune system. Hence, rise in the number of older people across the globe is estimated to create sizable business opportunities in the market for diabetic shoes.
Deep vein thrombosis (DVT) is one of the prevalent health condition found in diabetic people. If ignored, DVT can result into severe health complications. Diabetic shoes are gaining traction owing to their ability to help in minimizing the complications pertaining to DVT. Hence, rise in the product adoption among diabetic population is generating sizable sales prospects in the global diabetic shoes market. Moreover, the market is being driven by growing inclination among diabetic people toward accepting a healthy lifestyle.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Diabetic Shoes Market
Players Focus on Product Innovations in Diabetic Shoes
Some of the key companies operating in the global diabetic shoes market include Podartis Srl., Aetrex Worldwide, Inc., Dr. Comfort, LLC., Etonic Worldwide LLC, Apex Foot Health Industries LLC, Advance Diabetic Solution, DARCO International, Inc, Dr Zen Products, Inc. Drew Shoe Corporation, and Orthofeet Inc.
The presence of many players makes the competition levels in the diabetic shoes market highly intense, thereby entry of new companies difficult. Enterprises in the market for diabetic shoes are using different strategies such as collaborations, mergers, and acquisitions in order to expand their businesses in newer regions. Such efforts are prognosticated to drive the growth in the market. Leading players in the diabetic shoes market are focusing on the development of innovative products. Hence, they are seen investing heavily in R&Ds projects. These factors are expected to help in the market expansion in the forthcoming years.
Asia Pacific: Prominent Region Showing Sizable Business Avenues in Diabetic Shoes Market
Europe, North America, Middle East & Africa, Asia Pacific, and South America are some of the key regions in the global diabetic shoes market. Of them, Asia Pacific is one of the fastest growing market for diabetic shoes. Some of the key factors fueling the growth in the Asia Pacific diabetic shoes market include the presence of older and diabetic population in many regional nations including Japan and China. Moreover, the Asia Pacific market is estimated to gain the profitable prospects in the forthcoming years as several regional nations are focusing on the development of sturdy healthcare infrastructure, note analysts of a study by TMR.